Anthony Kebba

Summary

Affiliation: Imperial College
Country: UK

Publications

  1. ncbi Expression of the common heat-shock protein receptor CD91 is increased on monocytes of exposed yet HIV-1-seronegative subjects
    Anthony Kebba
    Department of Immunology, Imperial College, Chelsea and Westminster Hospital, London, UK
    J Leukoc Biol 78:37-42. 2005
  2. ncbi Distinct patterns of peripheral HIV-1-specific interferon- gamma responses in exposed HIV-1-seronegative individuals
    Anthony Kebba
    Department of Immunology, Imperial College, London, Chelsea and Westminster Hospital, London, United Kingdom
    J Infect Dis 189:1705-13. 2004
  3. ncbi HIV type 1 antigen-responsive CD4+ T-lymphocytes in exposed yet HIV Type 1 seronegative Ugandans
    Anthony Kebba
    Medical Research Council s Programme on AIDS in Uganda, UVRI, Entebbe, Uganda
    AIDS Res Hum Retroviruses 20:67-75. 2004
  4. ncbi Recent HIV-1 infection in a high-risk Ugandan cohort: implications for Phase IIB test-of-concept HIV vaccine trials
    Anthony Kebba
    Medical Research Council Research Unit on AIDS, Uganda Virus Research Institute, Plot 51 59, Nakiwogo Road, PO Box 49, Entebbe, Uganda
    Pharmacogenomics 8:409-14. 2007
  5. ncbi Therapeutic responses to AZT + 3TC + EFV in advanced antiretroviral naive HIV type 1-infected Ugandan patients
    Anthony Kebba
    Joint Clinical Research Center, Kampala, Uganda
    AIDS Res Hum Retroviruses 18:1181-7. 2002
  6. ncbi Antiretroviral therapy in sub-Saharan Africa: myth or reality?
    Anthony Kebba
    Medical Research Council Programme on AIDS in Uganda, Uganda Virus Research Institute, Entebbe, Uganda
    J Antimicrob Chemother 52:747-9. 2003
  7. ncbi Decreased serum opsonic activity against Streptococcus pneumoniae in human immunodeficiency virus-infected Ugandan adults
    Hidehiko Takahashi
    Department of Internal Medicine, Institute of Tropical Medicine, Nagasaki University, Sakamoto, Nagasaki, Japan
    Clin Infect Dis 37:1534-40. 2003

Collaborators

Detail Information

Publications7

  1. ncbi Expression of the common heat-shock protein receptor CD91 is increased on monocytes of exposed yet HIV-1-seronegative subjects
    Anthony Kebba
    Department of Immunology, Imperial College, Chelsea and Westminster Hospital, London, UK
    J Leukoc Biol 78:37-42. 2005
    ..7, P = 0.015). Increased surface expression of CD91 on CD14(+) monocytes is associated with the apparent HIV-1 resistance that is observed in ESN subjects...
  2. ncbi Distinct patterns of peripheral HIV-1-specific interferon- gamma responses in exposed HIV-1-seronegative individuals
    Anthony Kebba
    Department of Immunology, Imperial College, London, Chelsea and Westminster Hospital, London, United Kingdom
    J Infect Dis 189:1705-13. 2004
    ..Immunodominant peptides recognized by SP subjects tended to be from relatively conserved regions, whereas peptides recognized by ESN individuals were associated with slow disease progression...
  3. ncbi HIV type 1 antigen-responsive CD4+ T-lymphocytes in exposed yet HIV Type 1 seronegative Ugandans
    Anthony Kebba
    Medical Research Council s Programme on AIDS in Uganda, UVRI, Entebbe, Uganda
    AIDS Res Hum Retroviruses 20:67-75. 2004
    ....
  4. ncbi Recent HIV-1 infection in a high-risk Ugandan cohort: implications for Phase IIB test-of-concept HIV vaccine trials
    Anthony Kebba
    Medical Research Council Research Unit on AIDS, Uganda Virus Research Institute, Plot 51 59, Nakiwogo Road, PO Box 49, Entebbe, Uganda
    Pharmacogenomics 8:409-14. 2007
    ..Data also suggest that efficacy on post-infection end points may depend on whether transmission pairs are matched or mismatched for HLA class I alleles...
  5. ncbi Therapeutic responses to AZT + 3TC + EFV in advanced antiretroviral naive HIV type 1-infected Ugandan patients
    Anthony Kebba
    Joint Clinical Research Center, Kampala, Uganda
    AIDS Res Hum Retroviruses 18:1181-7. 2002
    ..These findings reflect significant efficacy in the use of AZT + 3TC + EFV in advanced ARV naive non-B subtype HIV-1-infected patients. The therapeutic responses were comparable to those previously described in the western world...
  6. ncbi Antiretroviral therapy in sub-Saharan Africa: myth or reality?
    Anthony Kebba
    Medical Research Council Programme on AIDS in Uganda, Uganda Virus Research Institute, Entebbe, Uganda
    J Antimicrob Chemother 52:747-9. 2003
  7. ncbi Decreased serum opsonic activity against Streptococcus pneumoniae in human immunodeficiency virus-infected Ugandan adults
    Hidehiko Takahashi
    Department of Internal Medicine, Institute of Tropical Medicine, Nagasaki University, Sakamoto, Nagasaki, Japan
    Clin Infect Dis 37:1534-40. 2003
    ..Our findings suggest that the opsonic activity of type-specific IgG is impaired in the serum of HIV-1-infected African adults, which may expose them to a serious risk of invasive pneumococcal infections...